Standout Papers

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression 2017 2026 2020 2023 745
  1. PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression (2017)
    Shiping Jiao, Weiya Xia et al. Clinical Cancer Research
  2. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion (2018)
    Jung-Mao Hsu, Weiya Xia et al. Nature Communications
  3. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade (2019)
    Ying Zhu, Jing Yang et al. Gut
  4. TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis (2021)
    Zhou Jiang, Seung-Oe Lim et al. Journal of Clinical Investigation

Immediate Impact

2 by Nobel laureates 15 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
Nuclear export of circular RNA
2024 StandoutNature
9 intermediate papers

Works of Seung-Oe Lim being referenced

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
2017 Standout
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
2013 Nature
and 1 more

Author Peers

Author Last Decade Papers Cites
Seung-Oe Lim 1750 1602 821 956 17 3.3k
Marta Pàez‐Ribes 1833 988 456 1090 18 3.1k
Anushka Dongre 1973 1703 750 1118 14 3.6k
Julienne L. Carstens 1697 1841 594 879 16 3.3k
Adriana Eramo 2516 1876 631 1040 48 4.1k
Antonija Kreso 2113 1884 403 1251 11 3.6k
Linda Vatan 1626 2220 2377 797 24 4.1k
Catherine Wilson 1077 1304 955 616 19 2.7k
Bram De Craene 2421 1639 468 1102 28 3.7k
Margit A. Huber 2294 1802 394 1217 20 3.7k
P. Charles Lin 1869 1562 1542 828 35 4.1k

All Works

Loading papers...

Rankless by CCL
2026